We report the stabilization of the human IgG1 Fc fragment by engineered intradomain disulfide bonds. One of these bonds, which connects the N-terminus of the CH3 domain with the F-strand, led to an increase of the melting temperature of this domain by 10°C as compared to the CH3 domain in the context of the wild-type Fc region. Another engineered disulfide bond, which connects the BC loop of the CH3 domain with the D-strand, resulted in an increase of Tm of 5°C. Combined in one molecule, both intradomain disulfide bonds led to an increase of the Tm of about 15°C. All of these mutations had no impact on the thermal stability of the CH2 domain. Importantly, the binding of neonatal Fc receptor was also not influenced by the mutations. Overall, the stabilized CH3 domains described in this report provide an excellent basic scaffold for the engineering of Fc fragments for antigen-binding or other desired additional or improved properties. Additionally, we have introduced the intradomain disulfide bonds into an IgG Fc fragment engineered in C-terminal loops of the CH3 domain for binding to Her2/neu, and observed an increase of the Tm of the CH3 domain for 7.5°C for CysP4, 15.5°C for CysP2 and 19°C for the CysP2 and CysP4 disulfide bonds combined in one molecule.
References
[1]
Huber R, Deisenhofer J, Colman PM, Matsushima M, Palm W (1976) Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature 264: 415–420.
[2]
Wozniak-Knopp G, Bartl S, Bauer A, Mostageer M, Woisetschlager M, et al. (2010) Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties. Protein Eng Des Sel 23: 289–297.
[3]
Tischenko VM, Abramov VM, Zav'yalov VP (1998) Investigation of the cooperative structure of Fc fragments from myeloma immunoglobulin G. Biochemistry 37: 5576–5581.
[4]
Ghirlando R, Lund J, Goodall M, Jefferis R (1999) Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry. Immunol Lett 68: 47–52.
[5]
Demarest SJ, Rogers J, Hansen G (2004) Optimization of the antibody C(H)3 domain by residue frequency analysis of IgG sequences. J Mol Biol 335: 41–48.
[6]
Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, et al. (2009) Engineered human antibody constant domains with increased stability. J Biol Chem 284: 14203–14210.
[7]
Hagihara Y, Mine S, Uegaki K (2007) Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region. J Biol Chem 282: 36489–36495.
[8]
Jefferis R, Lund J, Pound JD (1998) IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 163: 59–76.
[9]
Burmeister WP, Gastinel LN, Simister NE, Blum ML, Bjorkman PJ (1994) Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 372: 336–343.
[10]
Burmeister WP, Huber AH, Bjorkman PJ (1994) Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372: 379–383.
[11]
Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, et al. (2000) The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol 37: 697–706.
[12]
Vaughn DE, Bjorkman PJ (1997) High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry 36: 9374–9380.
[13]
Vaughn DE, Milburn CM, Penny DM, Martin WL, Johnson JL, et al. (1997) Identification of critical IgG binding epitopes on the neonatal Fc receptor. J Mol Biol 274: 597–607.
[14]
Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C (1991) Sequences of Proteins of Immunological Interest 5th edn (US Department of Health and Human Services). NIH Publication No 91-3242.
[15]
Hider RC, Kupryszewski G, Rekowski P, Lammek B (1988) Origin of the positive 225–230 nm circular dichroism band in proteins. Its application to conformational analysis. Biophys Chem 31: 45–51.
[16]
Kotzia GA, Labrou NE (2009) Engineering thermal stability of L-asparaginase by in vitro directed evolution. FEBS J 276: 1750–1761.
[17]
Dahiyat BI (1999) In silico design for protein stabilization. Curr Opin Biotechnol 10: 387–390.
[18]
Gershenson A, Arnold FH (2000) Enzyme stabilization by directed evolution. Genet Eng (N Y) 22: 55–76.
[19]
Steipe B, Schiller B, Pluckthun A, Steinbacher S (1994) Sequence statistics reliably predict stabilizing mutations in a protein domain. J Mol Biol 240: 188–192.
[20]
Betz SF (1993) Disulfide bonds and the stability of globular proteins. Protein Sci 2: 1551–1558.
[21]
Saerens D, Conrath K, Govaert J, Muyldermans S (2008) Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains. J Mol Biol 377: 478–488.
[22]
Arbabi-Ghahroudi M, To R, Gaudette N, Hirama T, Ding W, et al. (2009) Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points. Protein Eng Des Sel 22: 59–66.
[23]
Deisenhofer J (1981) Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry 20: 2361–2370.
[24]
Powers DB, Amersdorfer P, Poul M, Nielsen UB, Shalaby MR, et al. (2001) Expression of single-chain Fv-Fc fusions in Pichia pastoris. J Immunol Methods 251: 123–135.
Schellman JA (1955) The stability of hydrogen-bonded peptide structures in aqueous solution. C R Trav Lab Carlsberg Chim 29: 230–259.
[27]
Pace CN, Grimsley GR, Thomson JA, Barnett BJ (1988) Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. J Biol Chem 263: 11820–11825.
[28]
McAuley A, Jacob J, Kolvenbach CG, Westland K, Lee HJ, et al. (2008) Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain. Protein Sci 17: 95–106.
[29]
Azuma H, Hayashi T, Dent JA, Ruggeri ZM, Ware J (1993) Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor. J Biol Chem 268: 2821–2827.
[30]
Furukawa Y, Torres AS, O'Halloran TV (2004) Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 23: 2872–2881.
[31]
Sowdhamini R, Srinivasan N, Shoichet B, Santi DV, Ramakrishnan C, et al. (1989) Stereochemical modeling of disulfide bridges. Criteria for introduction into proteins by site-directed mutagenesis. Protein Eng 3: 95–103.
[32]
Ruiz M, Lefranc MP (2002) IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics 53: 857–883.
